Gastroenterology Practice Data for Endoscopy Device Sales
14,000 gastroenterologists, high procedure volumes, and physician-owned ASCs make GI one of the most lucrative specialties for device and pharma vendors.
2026-04-09
Three Sales Channels
Endoscopy equipment
Scopes, accessories, AI-assisted polyp detection, and single-use endoscopes. High-volume practices (2,000+ procedures/year) consume significantly more disposables.
Biologic medications
Infliximab, adalimumab, ustekinumab, vedolizumab. GI practices with in-office infusion suites are primary targets. 340B participation changes drug acquisition economics.
ASC products and services
GI has high rates of physician-owned ASCs. Practice-owning GI physicians who also own ASCs control both clinical and purchasing decisions.
Frequently Asked Questions
How many gastroenterologists practice in the US?
Roughly 14,000, making GI the fourth-largest specialty. Heavily procedure-oriented with significant device and biologic pharma revenue.
What is the GI MSO consolidation trend?
GI Alliance, US Digestive Health, Gastro Health, and One GI are leading platforms. Consolidation changes purchasing authority from individual physicians to platform procurement.
Why does 340B matter for GI pharma?
Hospital-based GI practices in 340B acquire biologics at discounted prices, changing their infusion economics and pharma contracting strategy.
Sources and References
Related Resources
Get the Provider Data You Need
Tell us what you're looking for. We'll build a custom list matched to your target market.
Trusted by healthcare sales teams, medical device companies, and health IT vendors across the US.